Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2011 2
2012 3
2014 2
2015 1
2018 1
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim results.
Palmer CD, Rappaport AR, Davis MJ, Hart MG, Scallan CD, Hong SJ, Gitlin L, Kraemer LD, Kounlavouth S, Yang A, Smith L, Schenk D, Skoberne M, Taquechel K, Marrali M, Jaroslavsky JR, Nganje CN, Maloney E, Zhou R, Navarro-Gomez D, Greene AC, Grotenbreg G, Greer R, Blair W, Cao MD, Chan S, Bae K, Spira AI, Roychowdhury S, Carbone DP, Henick BS, Drake CG, Solomon BJ, Ahn DH, Mahipal A, Maron SB, Johnson B, Rousseau R, Yelensky R, Liao CY, Catenacci DVT, Allen A, Ferguson AR, Jooss K. Palmer CD, et al. Among authors: rappaport ar. Nat Med. 2022 Aug;28(8):1619-1629. doi: 10.1038/s41591-022-01937-6. Epub 2022 Aug 15. Nat Med. 2022. PMID: 35970920 Clinical Trial.
GRT-R910: a self-amplifying mRNA SARS-CoV-2 vaccine boosts immunity for ≥6 months in previously-vaccinated older adults.
Palmer CD, Scallan CD, Kraemer Tardif LD, Kachura MA, Rappaport AR, Koralek DO, Uriel A, Gitlin L, Klein J, Davis MJ, Venkatraman H, Hart MG, Jaroslavsky JR, Kounlavouth S, Marrali M, Nganje CN, Bae K, Yan T, Leodones K, Egorova M, Hong SJ, Kuan J, Grappi S, Garbes P, Jooss K, Ustianowski A. Palmer CD, et al. Among authors: rappaport ar. Nat Commun. 2023 Jun 6;14(1):3274. doi: 10.1038/s41467-023-39053-9. Nat Commun. 2023. PMID: 37280238 Free PMC article.
Engineering of a miniaturized, robotic clinical laboratory.
Nourse MB, Engel K, Anekal SG, Bailey JA, Bhatta P, Bhave DP, Chandrasekaran S, Chen Y, Chow S, Das U, Galil E, Gong X, Gessert SF, Ha KD, Hu R, Hyland L, Jammalamadaka A, Jayasurya K, Kemp TM, Kim AN, Lee LS, Liu YL, Nguyen A, O'Leary J, Pangarkar CH, Patel PJ, Quon K, Ramachandran PL, Rappaport AR, Roy J, Sapida JF, Sergeev NV, Shee C, Shenoy R, Sivaraman S, Sosa-Padilla B, Tran L, Trent A, Waggoner TC, Wodziak D, Yuan A, Zhao P, Young DL, Robertson CR, Holmes EA. Nourse MB, et al. Among authors: rappaport ar. Bioeng Transl Med. 2018 Jan 19;3(1):58-70. doi: 10.1002/btm2.10084. eCollection 2018 Jan. Bioeng Transl Med. 2018. PMID: 29376134 Free PMC article.
A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results.
Rappaport AR, Kyi C, Lane M, Hart MG, Johnson ML, Henick BS, Liao CY, Mahipal A, Shergill A, Spira AI, Goldman JW, Scallan CD, Schenk D, Palmer CD, Davis MJ, Kounlavouth S, Kemp L, Yang A, Li YJ, Likes M, Shen A, Boucher GR, Egorova M, Veres RL, Espinosa JA, Jaroslavsky JR, Kraemer Tardif LD, Acrebuche L, Puccia C, Sousa L, Zhou R, Bae K, Hecht JR, Carbone DP, Johnson B, Allen A, Ferguson AR, Jooss K. Rappaport AR, et al. Nat Med. 2024 Mar 27. doi: 10.1038/s41591-024-02851-9. Online ahead of print. Nat Med. 2024. PMID: 38538867
MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia.
Chen C, Liu Y, Rappaport AR, Kitzing T, Schultz N, Zhao Z, Shroff AS, Dickins RA, Vakoc CR, Bradner JE, Stock W, LeBeau MM, Shannon KM, Kogan S, Zuber J, Lowe SW. Chen C, et al. Among authors: rappaport ar. Cancer Cell. 2014 May 12;25(5):652-65. doi: 10.1016/j.ccr.2014.03.016. Epub 2014 May 1. Cancer Cell. 2014. PMID: 24794707 Free PMC article.
A cluster of cooperating tumor-suppressor gene candidates in chromosomal deletions.
Xue W, Kitzing T, Roessler S, Zuber J, Krasnitz A, Schultz N, Revill K, Weissmueller S, Rappaport AR, Simon J, Zhang J, Luo W, Hicks J, Zender L, Wang XW, Powers S, Wigler M, Lowe SW. Xue W, et al. Among authors: rappaport ar. Proc Natl Acad Sci U S A. 2012 May 22;109(21):8212-7. doi: 10.1073/pnas.1206062109. Epub 2012 May 7. Proc Natl Acad Sci U S A. 2012. PMID: 22566646 Free PMC article.
Direct and indirect targeting of MYC to treat acute myeloid leukemia.
Brondfield S, Umesh S, Corella A, Zuber J, Rappaport AR, Gaillard C, Lowe SW, Goga A, Kogan SC. Brondfield S, et al. Among authors: rappaport ar. Cancer Chemother Pharmacol. 2015 Jul;76(1):35-46. doi: 10.1007/s00280-015-2766-z. Epub 2015 May 9. Cancer Chemother Pharmacol. 2015. PMID: 25956709 Free PMC article.
Mouse models of human AML accurately predict chemotherapy response.
Zuber J, Radtke I, Pardee TS, Zhao Z, Rappaport AR, Luo W, McCurrach ME, Yang MM, Dolan ME, Kogan SC, Downing JR, Lowe SW. Zuber J, et al. Among authors: rappaport ar. Genes Dev. 2009 Apr 1;23(7):877-89. doi: 10.1101/gad.1771409. Genes Dev. 2009. PMID: 19339691 Free PMC article.
14 results